Marcel Imwinkelried

Marcel Imwinkelried is the CEO of Siegfried, a Swiss contract manufacturer of pharmaceuticals. He has expressed the company's readiness to explore potential acquisitions and investments in the U.S. market as clients increasingly request additional production sources in response to tariff pressures. Imwinkelried is also mindful of the financial challenges facing smaller biotech firms, which rely heavily on contract manufacturers for their production needs.